Literature DB >> 6848455

The mediation of tissue eosinophilia in hypersensitivity reactions. IV. Production of delayed eosinophil chemotactic factor-a by peritoneal exudate cells from sensitized guinea-pigs in vitro.

M Hirashima, Y Hirotsu, H Hayashi.   

Abstract

An eosinophil chemotactic factor (ECF) was produced in the cell-free culture supernatants (CFS) of peritoneal exudate cells (PEC) from guinea-pigs immunized with dinitrophenyl derivatives of ascaris extract (DNP-As), when stimulated by the antigen in vitro without activation by immune complexes. A 2 or 6 hr pulse of the antigen was sufficient for ECF production, whereas long time incubation (48 hr) was required for the production of a sufficient amount of the factor. Treatment of PEC by cycloheximide resulted in the reduction of ECF production, suggesting that protein synthesis is essential. Its generation appeared carrier-specific and the source of the factor is presumed to be lymphocytes, probably T lymphocyte. The factor with a molecular weight of 70,000 shared a common antigenicity with delayed eosinophil chemotactic factor-a (delayed ECF-a), which was isolated from the skin lesions showing delayed tissue eosinophilia in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848455      PMCID: PMC1454007     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  The mediation of tissue eosinophilia in hypersensitivity reaction. I. Isolation of two different chemotactic factors from DNP-Ascaris extract-induced skin lesion in guinea-pig.

Authors:  M Hirashima; H Hayashi
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  Lymphocyte-derived eosinophil chemotactic factor. II. Studies on the mechanism of activation of the precursor substance by immune complexes.

Authors:  M Torisu; T Yoshida; P A Ward; S Cohen
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

4.  Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin.

Authors:  D G Colley
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

5.  Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

6.  Leucocyte chemotactic activity in the parallel bioassay of guinea--pig lymphokines.

Authors:  M F DeFranco; J M Hanson; J Morley; R A Wolstencroft; D C Dumonde
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

7.  In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils.

Authors:  S Cohen; P A Ward
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

8.  The peritoneal exudate lymphocyte. I. Differences in antigen responsiveness between peritoneal exudate and lymph node lymphocytes from immunized guinea pigs.

Authors:  D L Rosenstreich; J T Blake; A S Rosenthal
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

9.  On the relation of products of activated lymphocytes to cell-mediated cytolysis.

Authors:  C S Henney; J Gaffney; B R Bloom
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

10.  An eosinophil leukocyte chemotactic factor of anaphylaxis.

Authors:  A B Kay; D J Stechschulte; K F Austen
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

View more
  1 in total

1.  Isolation of an eosinophil chemotactic lymphokine as a natural mediator for eosinophil chemotaxis from concanavalin A-induced skin reaction sites in guinea-pigs.

Authors:  M Hirashima; K Tashiro; K Sakata; M Hirashima
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.